BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Gene therapy

  MeiraGTx, spying hope in a failed trial, buys back eye disease gene therapy from J&J

  J&J will hand over the rights to bota-vec for $25 million upfront, clearing MeiraGTx to seek regulatory approvals in the U.S. and EU in 2027.

  April 16, 2026

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  Oncotelic Therapeutics Reports FY 2025 Results Highlighting $249M Net Income and JV Pipeline Progress

  April 16, 2026

   · 

  13 min read
• Press Releases

  Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors

  April 16, 2026

   · 

  9 min read
• Press Releases

  Fate Therapeutics Announces Data Presentation of FT839 Next-Generation Off-The-Shelf CAR T-Cell Product Candidate for the Broad Treatment of Hematological Malignancies and Autoimmune Diseases Without the Need for Conditioning Chemotherapy at the AACR Annual Meeting

  April 16, 2026

   · 

  4 min read
• Press Releases

  MAIA Biotechnology Activates First U.S. Site for Ongoing International Phase 2 Expansion Trial of Novel Telomere Targeting Treatment Targeting Advanced Non-Small Cell Lung Cancer

  April 16, 2026

   · 

  7 min read
• Press Releases

  AIM ImmunoTech Enters Pivotal Value Inflection Phase with Planned Phase 3 Study of Ampligen® in Pancreatic Cancer, Backed by Positive Clinical Signals, Orphan Drug Status, and Global IP

  April 16, 2026

   · 

  7 min read
• Press Releases

  NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update

  April 16, 2026

   · 

  13 min read
• Press Releases

  Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

  April 16, 2026

   · 

  4 min read
• Press Releases

  Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026

  April 16, 2026

   · 

  8 min read
• Press Releases

  Femasys Drives International Growth with Israeli Market Entry for Fertility Portfolio

  April 16, 2026

   · 

  6 min read